首页|血清GLP-1、Sirt1水平与绝经后骨质疏松患者骨密度和骨代谢的相关性

血清GLP-1、Sirt1水平与绝经后骨质疏松患者骨密度和骨代谢的相关性

扫码查看
目的 探讨血清胰高血糖素样肽 1(GLP-1)、沉默信息调节因子 1(Sirt1)水平与绝经后骨质疏松(PMOP)患者骨密度和骨代谢的相关性.方法 选择 2021 年 1 月至 2023 年 5 月收治的 128 例PMOP患者(PMOP组)和62 例健康志愿者(对照组).检测血清 GLP-1、Sirt1 水平、骨密度,以及骨代谢指标Ⅰ型胶原氨基端前肽(PⅠNP)、β-胶原降解产物(β-CTX)、甲状旁腺素(PTH)、骨桥蛋白(OPN)、骨钙素(OC).Pearson系数分析GLP-1、Sirt1 与骨密度以及骨代谢指标的相关性.多因素Logistic回归分析PMOP的影响因素,受试者工作特征(ROC)分析GLP-1、Sirt1 诊断PMOP的价值.结果 PMOP组绝经年龄早于对照组,绝经年数大于对照组,体质量指数、骨密度(腰椎骨密度,双侧股骨颈骨密度,全髋骨密度)、血清PⅠNP、OPN、OC、GLP-1、Sirt1 水平低于对照组,血清β-CTX、PTH、血磷水平高于对照组(P<0.05).PMOP患者血清GLP-1、Sirt1 水平与骨密度、PⅠNP、OPN、OC呈正相关(P<0.05),与β-CTX、PTH呈负相关(P<0.05).绝经年数较长是PMOP的危险因素(P<0.05),而补充钙剂、高水平GLP-1、高水平Sirt1 是PMOP的保护因素(P<0.05).GLP-1、Sirt1 诊断PMOP的曲线下面积为0.789、0.779,联合GLP-1、Sirt1 诊断PMOP的曲线下面积为0.908,高于单独诊断(P<0.05).结论 PMOP血清GLP-1、Sirt1 水平偏低,且与骨密度降低以及骨代谢异常有关,联合检测GLP-1、Sirt1 水平有助于识别PMOP风险.
Correlation Between Serum GLP-1 and Sirt1 Levels and Bone Mineral Density and Bone Metabolism in Postmenopausal Patients with Osteoporosis
Objective To investigate the correlation between serum glucagon-like peptide 1(GLP-1)and silence-in-formation regulatory factor 1(Sirt1)levels and bone mineral density and bone metabolism in postmenopausal osteoporosis(PMOP)patients.Methods A total of 128 PMOP patients(PMOP group)and 62 healthy volunteers(control group)were selected from January 2021 to May 2023.Serum levels of GLP-1,Sirt1,bone mineral density,and bone metabolism indexes of type I collagen amine-terminal propeptide(PⅠNP),β-collagen degradation products(β-CTX),parathyroid hormone(PTH),osteopontin(OPN),osteocalcin(OC)were detected.Pearson coefficient was used to analyze the correlation be-tween GLP-1,Sirt1 and bone mineral density and bone metabolism.The influence factors of PMOP were analyzed by multiva-riate Logistic regression,and the value of GLP-1 and Sirt1 in the diagnosis of PMOP was analyzed by receiver operating char-acteristics(ROC).Results The menopause age of PMOP group was earlier than that of control group,the number of meno-pause years was longer than that of control group,the body mass index,bone mineral density(lumbar bone mineral density,bilateral femoral neck bone mineral density,total hip bone mineral density),serum PⅠNP,OPN,OC,GLP-1 and Sirt1 lev-els were lower than those of control group,and serum β-CTX,PTH and blood phosphorus levels were higher than those of con-trol group(P<0.05).Serum GLP-1 and Sirt1 levels in PMOP patients were positively correlated with bone mineral density,PⅠNP,OPN and OC(P<0.05),and negatively correlated with β-CTX and PTH(P<0.05).Long menopause years were risk factors for PMOP(P<0.05),while calcium supplementation,high level of GLP-1 and high level of Sirt1 were protective factors for PMOP(P<0.05).The area under the curve of PMOP diagnosed by GLP-1 and Sirt1 was 0.789 and 0.779,and the area under the curve of PMOP diagnosed by GLP-1 and Sirt1 combined was 0.908,which was higher than that by single diagnosis(P<0.05).Conclusion Serum GLP-1 and Sirt1 levels of PMOP are low,which are associated with decreased bone mineral density and abnormal bone metabolism.Combined detection of GLP-1 and Sirt1 levels is helpful to identify the risk of PMOP.

Postmenopausal osteoporosisBone densityBone metabolismGlucagon-like peptide 1Silent informa-tion regulator 1

靳凯锋、仲伟涛

展开 >

100071 北京,国家电网公司北京电力医院骨二科

绝经后骨质疏松 骨密度 骨代谢 胰高血糖素样肽1 沉默信息调节因子1

2024

转化医学杂志
海军总医院

转化医学杂志

CSTPCD
影响因子:0.671
ISSN:2095-3097
年,卷(期):2024.13(8)